Antenatal and early postnatal dexamethasone treatment decreases cortisol secretion in preterm infants

Citation
R. Karlsson et al., Antenatal and early postnatal dexamethasone treatment decreases cortisol secretion in preterm infants, HORMONE RES, 53(4), 2000, pp. 170-176
Citations number
34
Categorie Soggetti
Endocrinology, Nutrition & Metabolism
Journal title
HORMONE RESEARCH
ISSN journal
03010163 → ACNP
Volume
53
Issue
4
Year of publication
2000
Pages
170 - 176
Database
ISI
SICI code
0301-0163(2000)53:4<170:AAEPDT>2.0.ZU;2-F
Abstract
Glucocorticoids are used antenatally to accelerate the maturation of fetal respiratory and cardiovascular systems when a threat of preterm delivery ex ists. Postnatally, they are used to prevent and treat respiratory distress syndrome. This study investigates the effects of antenatal (ACT) and early postnatal corticosteroid treatment (PCT) on serum cortisol and plasma catec holamine and adenosine 3',5'-cyclic monophosphate (cAMP) concentrations in preterm neonates. The infants in the ACT group had a significantly lower co rtisol concentration than the infants in the non-ACT group on the first day of life. After birth, the infants were further divided into non-PCT and PC T groups. PCT suppressed cortisol levels significantly after 2 days, and th e cortisol levels were still lower 2 days after discontinuation of PCT. No effect of PCT on plasma cAMP or catecholamine concentrations was observed. The results indicate that both ACT and a short PCT can significantly suppre ss basal cortisol levels in preterm infants. Copyright (C) 2000 S. Karger A G, Basel.